Sponsor Pipeline

Hangzhou Highlightll Pharmaceutical Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
2
Recruiting
3
Phase 3
2
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-13 NCT07764003 A Study of Efficacy and Safety of TLL-018 in CSU Participants With Inadequate Response to… Phase 2 Not Yet Recruiting
2026-08-06 NCT07748728 TLL-018 in Patients With Moderate to Severe Active Rheumatoid Arthritis With Inadequate… Phase 2 Not Yet Recruiting
Active Trials by Phase
Phase 3
3
Phase 2
2
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06887127 A Long-term Extension Clinical Study of TLL-018 in Patients With Rheumatoid Arthritis Rheumatoid Arthritis Recruiting
NCT06020144 A Phase 3 Study Comparing TLL-018 to Tofacitinib in RA Subjects With Inadequate Response… Rheumatoid Arthritis Active, Not Recruiting
NCT06396026 A Study of Efficacy and Safety of TLL-018 in CSU Participants Chronic Spontaneous Urticaria Active, Not Recruiting
Phase 2
NCT07748728 TLL-018 in Patients With Moderate to Severe Active Rheumatoid Arthritis With Inadequate… Rheumatoid Arthritis (RA) Not Yet Recruiting
NCT07764003 A Study of Efficacy and Safety of TLL-018 in CSU Participants With Inadequate Response to… Chronic Spontaneous Urticaria (CSU) Not Yet Recruiting
Phase 1/2
NCT07629778 HL-300 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis Atopic Dermatitis Recruiting
NCT07665996 A Phase Ib/IIa Study Assessing the Rapid Onset Characteristics of TLL-018 for… Chronic Spontaneous Urticaria (CSU) Not Yet Recruiting
Disease Areas
Get alerts when Hangzhou Highlightll Pharmaceutical Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free